Percutaneous Assisted Approach for Total Hip Replacement and it's Effect on Functional Rehabilitation.

January 8, 2014 updated by: Claudia Hendrickx, Universiteit Antwerpen

Percutaneous Assisted Approach for Total Hip Replacement and it's Effect on Functional Rehabilitation Compared to the Anterolateral Approach.

The purpose of this study is to investigate whether revalidation following total hip replacement through the percutaneous approach is faster or better than following the anterolateral approach. We assume this would be the case since it is possible to spare a large part of the gluteus medius muscle with the percutaneous approach.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Antwerp, Belgium, 2000
        • Recruiting
        • UZA
        • Contact:
        • Principal Investigator:
          • Claudia Hendrickx, Phd Student
    • Antwerp
      • Wilrijk, Antwerp, Belgium, 2020
        • Recruiting
        • ZNA Middelheim
        • Principal Investigator:
          • Peter Mertens, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • unilateral hip arthritis or avascular necrosis (AVN) in need for total hip replacement

Exclusion Criteria:

  • Comorbidities affecting functional outcome
  • Symptomatic lumbar pathology
  • Need of surgery or intervention on the ipsilateral knee and/or ankle/foot
  • Neurological disorders such as Parkinsonism and previous cardiovascular accidents (CVA)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Percutaneous assisted approach
In this technique, a second small incision (1 cm) at the anterior border of the femur is made. A canulla is placed underneath the muscle and used to pass the reamers in the direction of the acetabulum. There's no need to enlarge the skin incision or to release more muscle insertion to achieve good working access to the acetabulum. Two advantages can be defined: sparing of the gluteus medius muscle and safe access to the acetabulum to obtain perfect positioning of the implants.
All patients will get a standard total hip replacement (cementless hydroxyapatite coated cup and a titanium plasmasprayed stem) with a ceramic on ceramic (third generation biolox delta) couple. Preoperative leg length and offset are marked to reconstruct the preoperative leg length and to obtain the optimal offset.
Both groups will receive usual care (UC) after surgery. This includes standard physiotherapy care consisting of mobilizing and strengthening techniques. All patients will receive a booklet containing information about the surgery, weight bearing after the surgery, and rehabilitation in general.
Active Comparator: Anterolateral approach
A standard transgluteal approach is used. This means a large part of the gluteus medius muscle is released to obtain good access to the acetabulum.
All patients will get a standard total hip replacement (cementless hydroxyapatite coated cup and a titanium plasmasprayed stem) with a ceramic on ceramic (third generation biolox delta) couple. Preoperative leg length and offset are marked to reconstruct the preoperative leg length and to obtain the optimal offset.
Both groups will receive usual care (UC) after surgery. This includes standard physiotherapy care consisting of mobilizing and strengthening techniques. All patients will receive a booklet containing information about the surgery, weight bearing after the surgery, and rehabilitation in general.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change in time needed for the timed get up and go test
Time Frame: baseline, 4 weeks, 12 weeks
The subject is asked to stand up from a chair, walk 3m to a cone, return to the chair and sit down again. The time needed to perform this test is recorded in seconds.
baseline, 4 weeks, 12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
surface electromyography (sEMG) of gluteus medius
Time Frame: baseline
sEMG of the gluteus medius is recorded during maximally voluntary isometric contraction and during single leg stance.
baseline
Change in hip abductor muscle strength measured by MicroFET 2
Time Frame: baseline, 4 weeks, 12 weeks
The patient lies supine. Resistance is administered on the lateral side of the leg, just proximal of the knee joint. Patients will be asked for a maximally voluntary isometric contraction. The test will be repeated 3 times. The mean value will be recorded.
baseline, 4 weeks, 12 weeks
Change in knee extensor muscle strength measured by MicroFET 2
Time Frame: baseline, 4 weeks, 12 weeks
The patient is seated with the hips and knees bent 90°. Resistance is administered on the ventral side of the leg, just proximal of the ankle joint. Patients will be asked for a maximally voluntary isometric contraction. The test will be repeated 3 times. The mean value will be recorded.
baseline, 4 weeks, 12 weeks
Score on the Trendelenburg test
Time Frame: baseline

The patient is asked to raise one leg (sound side) and lift the non-stance side of the pelvis as high as possible for 30 seconds. The response is classified as followed:

  1. Normal: the pelvis on the non-stance side can be lifted maximally during 30 seconds
  2. The pelvis on the non-stance side can be lifted, but not maximally
  3. The pelvis on the non-stance side is elevated, but not maintained for 30 seconds.
  4. No elevating of the pelvis on the non-stance side
  5. Drooping of the pelvis
  6. Non-valid response: due to hip pain or uncooperative patient
baseline
Change in score on the Oxford Hip Score
Time Frame: baseline, 4 weeks, 12 weeks
The Oxford Hip Score (OHS) is a disease-specific questionnaire that consists of 12 questions for the evaluation of pain and hip function in relation to various activities. Each question contains 5 quantifiable answers, leading to a total score that can range from 12 (least problems) to 60 (most problems).
baseline, 4 weeks, 12 weeks
Change in score on the SF-36 and it's subscales
Time Frame: baseline, 4 weeks, 6 weeks
The SF-36 is a generic questionnaire that contains 36 items measuring health on 8 different dimensions. These dimensions cover functional status, wellbeing and overall evaluation of health.
baseline, 4 weeks, 6 weeks
Change in time needed to complete the 5 times sit-to-stand test
Time Frame: baseline, 4 weeks, 12 weeks
This easily feasible test where the patient has to stand up and sit back down 5 times as fast as possible is a good predictor of falling. A worse score (i.e. a longer time needed to complete the test) on the 5 times sit to stand (5tSTS) implies a greater chance of falling.
baseline, 4 weeks, 12 weeks
Change in distance walked during the 6 minute walking test
Time Frame: baseline, 4 weeks, 12 weeks
The test measures the distance a patient can quickly walk on a flat, hard surface in a time-period of 6 minutes.
baseline, 4 weeks, 12 weeks
surface electromyography (sEMG) of gluteus medius
Time Frame: 4 weeks
sEMG of the gluteus medius is recorded during maximally voluntary isometric contraction and during single leg stance.
4 weeks
surface electromyography (sEMG) of gluteus medius
Time Frame: 12 weeks
sEMG of the gluteus medius is recorded during maximally voluntary isometric contraction and during single leg stance.
12 weeks
Score on the trendelenburg test
Time Frame: 4 weeks

The patient is asked to raise one leg (sound side) and lift the non-stance side of the pelvis as high as possible for 30 seconds. The response is classified as followed:

  1. Normal: the pelvis on the non-stance side can be lifted maximally during 30 seconds
  2. The pelvis on the non-stance side can be lifted, but not maximally
  3. The pelvis on the non-stance side is elevated, but not maintained for 30 seconds.
  4. No elevating of the pelvis on the non-stance side
  5. Drooping of the pelvis
  6. Non-valid response: due to hip pain or uncooperative patient
4 weeks
Score on the Trendelenburg test
Time Frame: 12 weeks

The patient is asked to raise one leg (sound side) and lift the non-stance side of the pelvis as high as possible for 30 seconds. The response is classified as followed:

  1. Normal: the pelvis on the non-stance side can be lifted maximally during 30 seconds
  2. The pelvis on the non-stance side can be lifted, but not maximally
  3. The pelvis on the non-stance side is elevated, but not maintained for 30 seconds.
  4. No elevating of the pelvis on the non-stance side
  5. Drooping of the pelvis
  6. Non-valid response: due to hip pain or uncooperative patient
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Claudia Hendrickx, PhD student, Universiteit Antwerpen

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2013

Primary Completion (Anticipated)

December 1, 2014

Study Registration Dates

First Submitted

January 7, 2014

First Submitted That Met QC Criteria

January 8, 2014

First Posted (Estimate)

January 9, 2014

Study Record Updates

Last Update Posted (Estimate)

January 9, 2014

Last Update Submitted That Met QC Criteria

January 8, 2014

Last Verified

January 1, 2014

More Information

Terms related to this study

Other Study ID Numbers

  • B300201318915

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Total Hip Arthroplasty

Clinical Trials on Ceramic on ceramic couple

3
Subscribe